Australia markets closed

Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. (300452.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
12.44-0.28 (-2.20%)
At close: 03:04PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 2.92B
Enterprise value 2.57B
Trailing P/E 18.57
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.62
Price/book (mrq)3.26
Enterprise value/revenue 3.09
Enterprise value/EBITDA 13.32

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-30.23%
S&P500 52-week change 322.36%
52-week high 319.47
52-week low 39.92
50-day moving average 312.60
200-day moving average 314.07

Share statistics

Avg vol (3-month) 33.1M
Avg vol (10-day) 32.88M
Shares outstanding 5234.44M
Implied shares outstanding 6239.72M
Float 8141.54M
% held by insiders 142.45%
% held by institutions 18.02%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.25
Forward annual dividend yield 42.01%
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 41.48
Payout ratio 437.31%
Dividend date 3N/A
Ex-dividend date 417 May 2023
Last split factor 21.3:1
Last split date 326 May 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 19.53%
Operating margin (ttm)22.57%

Management effectiveness

Return on assets (ttm)7.70%
Return on equity (ttm)18.20%

Income statement

Revenue (ttm)829.23M
Revenue per share (ttm)3.53
Quarterly revenue growth (yoy)-4.00%
Gross profit (ttm)N/A
EBITDA 208.89M
Net income avi to common (ttm)161.96M
Diluted EPS (ttm)0.67
Quarterly earnings growth (yoy)0.90%

Balance sheet

Total cash (mrq)650.88M
Total cash per share (mrq)2.74
Total debt (mrq)299.93M
Total debt/equity (mrq)31.13%
Current ratio (mrq)3.90
Book value per share (mrq)3.77

Cash flow statement

Operating cash flow (ttm)123.33M
Levered free cash flow (ttm)53.61M